Cargando…
Survival from cutaneous malignant melanoma is improving, but is it because of a trend in decreasing melanoma thickness or the advent of new ‘revolutionary’ therapeutics?
Linked Article: Zamagni et al. Br J Dermatol 2022; 187:52–63.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542168/ https://www.ncbi.nlm.nih.gov/pubmed/35415923 http://dx.doi.org/10.1111/bjd.21583 |